.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Glycogen Synthase Kinase-3 (GSK-3) and Its Inhibitors
Martinez
€ 195.69
FREE Delivery in Ireland
Description for Glycogen Synthase Kinase-3 (GSK-3) and Its Inhibitors
Hardcover. GSK-3 is a promising drug target that has been extensively tested, and shown great potential for treatment of diseases that have no current effective treatment - like Alzheimer's, bipolar disorder, and cancer. Editor(s): Martinez, Ana; Castro, Ana; Medina, Miguel. Series Editor(s): Wang, Binghe. Series: Wiley Series in Drug Discovery and Development. Num Pages: 346 pages, Illustrations (some col.). BIC Classification: PNN; PS. Category: (P) Professional & Vocational. Dimension: 235 x 162 x 24. Weight in Grams: 680.
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It’s a great reference for researchers in drug design and development.
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It’s a great reference for researchers in drug design and development.
Product Details
Format
Hardback
Publication date
2006
Publisher
John Wiley & Sons Inc United States
Number of pages
346
Condition
New
Series
Wiley Series in Drug Discovery and Development
Number of Pages
384
Place of Publication
, United States
ISBN
9780471770015
SKU
V9780471770015
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-1
About Martinez
ANA MARTINEZ is the Research and Development Director for NeuroPharma. She has been and still is an active researcher in the design and synthesis of GSK-3 inhibitors. ANA CASTRO is the Medicinal Chemistry Director of NeuroPharma. She was formerly a tenured scientist at the Medicinal Chemistry Institute. MIGUEL MEDINA is the Drug Discovery Director at NeuroPharma. He ... Read more
Reviews for Glycogen Synthase Kinase-3 (GSK-3) and Its Inhibitors